top headlines
The European Medicines Agency (EMA) has accepted Almirall’s application to [...]
A 10-year NHS-led study has found that focal therapy can [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Mission Therapeutics has signed a deal worth up to US$292 [...]
Medicus Pharma has received positive feedback from FDA and central [...]
Compass Pathways has published a post hoc analysis of its [...]
Kairos Pharma has reported positive interim safety results from an [...]
Rani Therapeutics has reported positive initial Phase 1a data for [...]
Seegene has launched the Global Million Clinical Study (GMCS), an [...]
